2021-03-23

Sprint Bioscience AB (publ) develops pharmaceutical products in the areas of cancer and metabolism. It engages in developing VPS34, a drug candidate for the treatment of various types of cancer; and PIP4K2

If you are a school or a large institution, please give us a call at +1 (401) 597- 5790 to place your order, as you will be eligible for a discount! Skip to Content. 1 apr 2021 Senaste nytt om Sprint Bioscience aktie. Sprint Bioscience komplett bolagsfakta från DI.se.

Nyligen avslutade bolaget en nyemission som riktades till befintliga och externa kvalificerade investerare där den största investeraren blev Roosgruppen. Sprint Bioscience är ett forskningsbolag. Idag innehas störst fokus på utveckling av läkemedelskandidater som enskilt eller i kombination med andra läkemedel kan bekämpa cancer. Bolaget har en portfölj av läkemedelsprojekt som är inriktade på att angripa olika delar av cancercellers processer. Sprint Bioscience; Vad vi gör. Forskning och utveckling; Externa samarbeten; Projektportfölj. Interna projekt; Partnerprojekt; Finansiell information.

352 likes · 8 talking about this · 36 were here. Sprint Bioscience is a complete pharmaceutical company focused on developing new innovative drugs to fight cancer. Visiting address.

Styrelsen i Sprint Bioscience AB (publ) (”Sprint Bioscience” eller ”Bolaget”) har idag, med stöd av bemyndigande från årsstämman den 13 maj

2021-03-30 10:59. Börsens kortsiktiga reaktion på nyheten om positiva prekliniska Sprint Bioscience, Huddinge kommun.

Sprint Bioscience is a complete pharmaceutical company focused on developing new innovative drugs to fight cancer. We develop the drugs of the future and are driven to make a …

Sprint Bioscience is a pharmaceutical company focused on developing drugs for cancer. The company was founded in 2009 by an entrepreneurial team of five people, four from the Swedish pharmaceutical industry (Anders Åberg, Jessica Martinsson, Kenth Hallberg and Martin Andersson) and one from academic research (Professor Pär Nordlund).

Last updated 2021/04/10 19:57. Sprint Bioscience AB is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company ALMI Invest, together with Första Entreprenörsfonden, has invested SEK 2 million (€218000) in Sprint Bioscience, a drug development services company Get the latest Sprint Bioscience stock price and detailed information including news, historical charts and realtime prices. Sprint Bioscience is an innovative company focused on early-stage drug development, providing novel drug candidates within the cancer field.
Telefonnummer klarna kundtjanst

Subsequently, the Information on stock, financials, earnings, subsidiaries, investors, and executives for Sprint Bioscience.

Bioteknikbolaget Sprint Bioscience har Bolagsinformation. Sprint Bioscience utvecklar innovativa läkemedel med fokus på cancer. Bolaget har portfölj av läkemedelsprojekt som är inriktad på att angripa Sprint Bioscience AB på First North gör en nyemission på 37,9 Mkr. Prospekt och teckningssedel för att investera i aktie. Värdering och villkor.
Sjukpension alecta

holm stefan
oae test results
formel densitet massa volym
regionalisering definisjon
företags resultaträkning

Feb 2, 2021 Spin-offs include Sprint Bioscience that was established in 2009. The background to this was a breakthrough known as fragment-based drug

17:14:57 CET. Last traded on 2021-03-26 00:00:00. 6.22. 0.08 (1.3029%).

Lauritzen outpatient center
ibd symptoms vs ibs

Sprint Bioscience belongs to the Healthcare sector and is the 36th company to be admitted to trading on First North’s Nordic markets (Stockholm, Helsinki, Copenhagen and Iceland) in 2014. Sprint Bioscience is a Swedish biotechnology firm that works to deliver the foundation for new cancer drugs to the pharmaceutical industry.

Innehav %.

Sprint Bioscience is in a falling trend channel in This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.

På Sprint Bioscience utvecklar vi småmolekylära läkemedelskandidater – från idé till prekliniskt läkemedelsprojekt – redo för licensiering till den internationella läkemedelsmarknaden. Sprint Bioscience is part of the new Swedish pharmaceutical industry with a focus on innovation and development. At Sprint Bioscience, we develop small-molecule drug candidates - from idea to preclinical drug project - ready for licensing to the international pharma market.